Reply

Nephrology Dialysis Transplantation

Volumn 23, Issue 4, 2008, Pages 1462-1463

  Churchwell, Mariann D ^a,b   Btaiche, Imad F ^b,c   Pasko, Deborah A ^b,c   Mueller, Bruce A ^b,c  

^a UNIVERSITY OF TOLEDO   (United States)

^b Renal Replacement Therapy Kinetic Study Group   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 GLOBULIN; GLUTATHIONE PEROXIDASE; SELENIUM;

ALBUMIN BLOOD LEVEL; BLOOD LEVEL; ENZYME ACTIVITY; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; LETTER; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BINDING; SEPSIS; SUPPLEMENTATION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 44449131390     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm822     Document Type: Letter

References (5)

1. Churchwell MD, Pasko DA, Btaiche IF et al. Trace element removal during in vitro and in vivo continuous haemodialysis. Nephrol Dial Transplant 2007; 22: 2970-2977
2. Berger MM, Chiolero RL. Antioxidant supplementation in sepsis and systemic inflammatory response syndrome. Crit Care Med 2007; 35 (9 Suppl): S584-S590
3. Forceville X, Vitoux D, Gauzit R et al. Selenium, systemic immune response syndrome, sepsis, and outcome in critically ill patients. Crit Care Med 1998; 26: 1536-1544
4. Yavuz O, Bicik Z, Cinar Y et al. The effect of different dialysis membranes on oxidative stress and selenium status. Clin Chim Acta 2004; 346: 153-160
5. Nichoalds GE. Selenium. In: Baumgartner TG (ed). The Clinical Guide to Parenteral Micronutrition. Fujisawa USA, Inc., 1997, 387-400